• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将治疗注意力缺陷多动障碍(ADHD)的药物与酒精及滥用药物联用是否存在任何潜在的危险药理学效应?一项文献系统综述。

Are there any potentially dangerous pharmacological effects of combining ADHD medication with alcohol and drugs of abuse? A systematic review of the literature.

作者信息

Barkla Xanthe M, McArdle Paul A, Newbury-Birch Dorothy

机构信息

Children and Young People's Service, Villa 9, Northgate Hospital, Morpeth, Northumberland, UK.

Institute of Health & Society, Newcastle University, Newcastle, UK.

出版信息

BMC Psychiatry. 2015 Oct 30;15:270. doi: 10.1186/s12888-015-0657-9.

DOI:10.1186/s12888-015-0657-9
PMID:26517983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4628434/
Abstract

BACKGROUND

Among young people up to 18 years of age, approximately 5% have attention deficit hyperactivity disorder (ADHD), many of whom have symptoms persisting into adulthood. ADHD is associated with increased risk of co-morbid psychiatric disorders, including substance misuse. Many will be prescribed medication, namely methylphenidate, atomoxetine, dexamphetamine and lisdexamfetamine. If so, it is important to know if interactions exist and if they are potentially toxic.

METHODS

Three databases (Medline, EMBASE and PsychINFO) from a 22 year period (1992 - June 2014) were searched systematically. Key search terms included alcohol, substance related disorders, methylphenidate, atomoxetine, dexamphetamine, lisdexamfetamine, and death, which identified 493 citations (344 after removal of duplicates). The eligibility of each study was assessed jointly by two investigators, leaving 20 relevant articles.

RESULTS

We identified only a minimal increase in side-effects when ADHD medication (therapeutic doses) was taken with alcohol. None of the reviewed studies showed severe sequelae among those who had overdosed on ADHD medication and other coingestants, including alcohol.

CONCLUSIONS

The numbers across all the papers studied remain too low to exclude uncommon effects. Also, studies of combined effects with novel psychoactive substances have not yet appeared in the literature. Nevertheless, no serious sequelae were identified from combining ADHD medication with alcohol/illicit substances from the pre-novel psychoactive substance era.

摘要

背景

在18岁以下的年轻人中,约5%患有注意力缺陷多动障碍(ADHD),其中许多人的症状会持续到成年期。ADHD与包括药物滥用在内的共病精神障碍风险增加有关。许多患者会被开具药物,即哌甲酯、托莫西汀、右旋苯丙胺和赖氨酸右旋苯丙胺。如果是这样,了解是否存在相互作用以及它们是否具有潜在毒性就很重要。

方法

系统检索了22年期间(1992年至2014年6月)的三个数据库(Medline、EMBASE和PsychINFO)。关键检索词包括酒精、物质相关障碍、哌甲酯、托莫西汀、右旋苯丙胺、赖氨酸右旋苯丙胺和死亡,共识别出493条引文(去除重复项后为344条)。由两名研究人员共同评估每项研究的合格性,最终留下20篇相关文章。

结果

我们发现,ADHD药物(治疗剂量)与酒精一起服用时,副作用仅略有增加。在所有综述研究中,没有一项显示ADHD药物与其他共同摄入物质(包括酒精)过量服用者出现严重后遗症。

结论

所有研究论文中的病例数仍然太少,无法排除罕见效应。此外,关于与新型精神活性物质联合作用的研究尚未见诸文献。然而,在新型精神活性物质时代之前,未发现ADHD药物与酒精/非法物质联合使用会导致严重后遗症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7784/4628434/0c73360a3f3a/12888_2015_657_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7784/4628434/0c73360a3f3a/12888_2015_657_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7784/4628434/0c73360a3f3a/12888_2015_657_Fig1_HTML.jpg

相似文献

1
Are there any potentially dangerous pharmacological effects of combining ADHD medication with alcohol and drugs of abuse? A systematic review of the literature.将治疗注意力缺陷多动障碍(ADHD)的药物与酒精及滥用药物联用是否存在任何潜在的危险药理学效应?一项文献系统综述。
BMC Psychiatry. 2015 Oct 30;15:270. doi: 10.1186/s12888-015-0657-9.
2
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.患有共病抽动障碍的儿童注意力缺陷多动障碍(ADHD)的药物治疗。
Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD007990. doi: 10.1002/14651858.CD007990.pub3.
3
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.
4
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.兴奋剂和非兴奋剂药物对 ADHD 儿童和青少年的心血管影响:哌醋甲酯、苯丙胺和托莫西汀的试验的系统评价和荟萃分析。
CNS Drugs. 2017 Mar;31(3):199-215. doi: 10.1007/s40263-017-0410-7.
5
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.成人注意缺陷多动障碍的药物治疗:系统评价和网络荟萃分析。
PLoS One. 2020 Oct 21;15(10):e0240584. doi: 10.1371/journal.pone.0240584. eCollection 2020.
6
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.兴奋剂和非兴奋剂药物治疗注意缺陷多动障碍和癫痫患者。
Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2.
7
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.
8
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).哌醋甲酯治疗注意缺陷多动障碍(ADHD)儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
9
Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine.儿童和青少年注意力缺陷多动障碍治疗的系统证据综合分析:赖氨酸安非他明与哌甲酯及托莫西汀的间接治疗比较
Curr Med Res Opin. 2014 Aug;30(8):1673-85. doi: 10.1185/03007995.2014.904772. Epub 2014 Apr 15.
10
Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.药物治疗注意缺陷多动障碍的成本效益:系统文献回顾。
CNS Drugs. 2012 Jul 1;26(7):581-600. doi: 10.2165/11633900-000000000-00000.

引用本文的文献

1
ADHD and Alcohol Use Disorder: Optimizing Screening and Treatment in Co-occurring Conditions.注意缺陷多动障碍与酒精使用障碍:优化共病情况下的筛查与治疗
CNS Drugs. 2025 May;39(5):457-472. doi: 10.1007/s40263-025-01168-6. Epub 2025 Feb 20.
2
Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement.注意缺陷/多动障碍与物质使用障碍患者的识别与治疗:专家共识声明
World J Psychiatry. 2023 Mar 19;13(3):84-112. doi: 10.5498/wjp.v13.i3.84.
3
Management of ADHD in Prisoners-Evidence Gaps and Reasons for Caution.

本文引用的文献

1
Awash in a sea of 'bath salts': implications for biomedical research and public health.深陷“浴盐”之海:对生物医学研究和公共卫生的影响
Addiction. 2014 Oct;109(10):1577-9. doi: 10.1111/add.12601. Epub 2014 Jul 1.
2
Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression.哌醋甲酯通过增加多巴胺转运蛋白的表达来增强安非他命的效力和强化作用。
Nat Commun. 2013;4:2720. doi: 10.1038/ncomms3720.
3
Epidemiological modelling of attention-deficit/hyperactivity disorder and conduct disorder for the Global Burden of Disease Study 2010.
囚犯注意力缺陷多动障碍的管理——证据空白与谨慎原因
Front Psychiatry. 2022 Mar 18;13:771525. doi: 10.3389/fpsyt.2022.771525. eCollection 2022.
4
Substance Use Among Adolescents with Attention-Deficit/Hyperactivity Disorder: Reasons for Use, Knowledge of Risks, and Provider Messaging/Education.注意缺陷多动障碍青少年的物质使用:使用原因、风险认知及医疗服务提供者的信息传递/教育
J Dev Behav Pediatr. 2017 Jul/Aug;38(6):417-423. doi: 10.1097/DBP.0000000000000461.
5
Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review.成人注意缺陷多动障碍的药物和非药物治疗:荟萃综述。
Evid Based Ment Health. 2017 Feb;20(1):4-11. doi: 10.1136/eb-2016-102415. Epub 2016 Dec 19.
6
Factors Associated With Musculoskeletal Injuries in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.注意缺陷多动障碍儿童及青少年肌肉骨骼损伤的相关因素
Prim Care Companion CNS Disord. 2016 Jun 23;18(3). doi: 10.4088/PCC.16m01937. eCollection 2016.
7
Emergency Department Visits for Adverse Drug Reactions Involving Alcohol: United States, 2005 to 2011.2005年至2011年美国因涉及酒精的药物不良反应而进行的急诊科就诊情况
Alcohol Clin Exp Res. 2016 Sep;40(9):1913-25. doi: 10.1111/acer.13167. Epub 2016 Aug 4.
2010 年全球疾病负担研究中注意缺陷多动障碍和品行障碍的流行病学建模。
J Child Psychol Psychiatry. 2013 Dec;54(12):1263-74. doi: 10.1111/jcpp.12144. Epub 2013 Oct 4.
4
Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination.单独或联合使用哌醋甲酯和摇头丸的药代动力学和药效学效应。
Int J Neuropsychopharmacol. 2014 Mar;17(3):371-81. doi: 10.1017/S1461145713001132. Epub 2013 Oct 8.
5
Toward systems neuroscience of shared and distinct neural effects of medications used to treat attention-deficit/hyperactivity disorder.
Biol Psychiatry. 2013 Oct 15;74(8):560-2. doi: 10.1016/j.biopsych.2013.08.021.
6
Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management.药物过量治疗注意力缺陷多动障碍:临床表现、毒性机制及处理方法。
CNS Drugs. 2013 Jul;27(7):531-43. doi: 10.1007/s40263-013-0084-8.
7
Amphetamines, atomoxetine and the risk of serious cardiovascular events in adults.安非他命、托莫西汀与成年人严重心血管事件风险。
PLoS One. 2013;8(1):e52991. doi: 10.1371/journal.pone.0052991. Epub 2013 Jan 30.
8
Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.共病成人注意缺陷多动障碍和成瘾患者的药物治疗和临床决策难题
Br J Clin Pharmacol. 2014 Feb;77(2):337-56. doi: 10.1111/bcp.12045.
9
Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.注意缺陷多动障碍药物治疗的严重心血管问题风险。
CNS Drugs. 2013 Jan;27(1):15-30. doi: 10.1007/s40263-012-0019-9.
10
Interactive effects of methylphenidate and alcohol on discrimination, conditioned place preference and motor coordination in C57BL/6J mice.哌醋甲酯和酒精对 C57BL/6J 小鼠辨别力、条件性位置偏爱和运动协调的交互作用。
Psychopharmacology (Berl). 2013 Feb;225(3):613-25. doi: 10.1007/s00213-012-2849-z. Epub 2012 Sep 7.